High-dose antithrombin III in the treatment of severe sepsis in patients with a high risk of death: Efficacy and safety*
Christian J. Wiedermann(Eurac Research), Steven M. Opal(Brown University), Mathias Juers, Heinz-Otto Keinecke, Helmut Ostermann(LMU Klinikum), Johannes Hoffmann, Joachim Kienast(University of Münster), Richard Strauß(Hennepin County Medical Center), Brian Warren(Stellenbosch University), Josef Briegel(LMU Klinikum)
Cited by 188
Related Papers
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
|JAMA|2016|28.1k
Surviving Sepsis Campaign
|Critical Care Medicine|2013|9.7k
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012
|Intensive Care Medicine|2013|7.3k
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
|Critical Care Medicine|2003|6k
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
|Intensive Care Medicine|2003|2.9k